Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
01/2005
01/27/2005US20050020592 Substituted heterocyclic compounds and methods of use
01/27/2005US20050020587 Nicotinamide derivatives useful as PDE4 inhibitors
01/27/2005US20050020586 Using 4-imidazoline ester or acid; antiinflammatory agents; microbiocides; bactericides; antitumor agents; autoimmune disease
01/27/2005US20050020585 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
01/27/2005US20050020583 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
01/27/2005US20050020581 4H-quinazolinyl compounds; alkylation of a quinazoline with a 3-bromopiperidine-2,6-dione followed by alkylation with a heterocyclic alkyl compound; immunomodulators with increased solubility and chemical resistance to hydrolysis; alternatives to thalidomide treatment for autoimmune diseases
01/27/2005US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
01/27/2005US20050020564 Pyrazole-amides and sulfonamides as sodium channel modulators
01/27/2005US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors
01/27/2005US20050020505 Angiogenesis inhibitors; antitumor agents; anticancer agents; atherosclerosis; cardiovascular disorders; antiarthritic agents
01/27/2005US20050020451 2,6 Substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
01/27/2005CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases
01/27/2005CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
01/27/2005CA2532057A1 Novel azaheterocyclic amides useful for treating pain
01/27/2005CA2531619A1 Biaryl piperazinyl-pyridine analogues
01/27/2005CA2531535A1 Substituted quinolin-4-ylamine analogues
01/27/2005CA2531508A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
01/27/2005CA2531507A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
01/27/2005CA2531401A1 Substituted heterocyclic diarylamine analogues
01/27/2005CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative
01/27/2005CA2528774A1 Small molecule toll-like receptor (tlr) antagonists
01/26/2005EP1500658A1 Novel thiol derivative, process for producing the same and use thereof
01/26/2005EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors
01/26/2005EP1500655A1 New methionine aminopeptidase inhibitor
01/26/2005EP1500653A1 Substituted arylpyrazines
01/26/2005EP1500652A1 Quinazoline derivative and medicine
01/26/2005EP1500648A1 Novel piperidine derivative
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections
01/26/2005EP1499609A2 Pesticidal heterocycles
01/26/2005EP1499608A1 Substituted imidazole derivatives: gaba a receptor ligands
01/26/2005EP1499607A1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
01/26/2005EP1499606A1 3, 4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
01/26/2005EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
01/26/2005EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells
01/26/2005EP1499594A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
01/26/2005EP1499593A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
01/26/2005EP1499591A1 Carboxylic acid amides
01/26/2005EP1499588A1 Melanocortin receptor ligands
01/26/2005EP1499319A1 Bicyclo 4.4.0 antiviral derivatives
01/26/2005EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
01/26/2005EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
01/26/2005EP1499313A2 Heterocyclic derivatives as opioid receptor modulators
01/26/2005EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors
01/26/2005EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same
01/26/2005EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
01/26/2005EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
01/26/2005EP1373255B1 Process for the preparation of imidazole compounds
01/26/2005EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
01/26/2005EP1243579B1 Process for the production of pyridine derivatives
01/26/2005EP1120409B1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation
01/26/2005EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
01/26/2005EP1082303B1 Heterocyclic derivatives which inhibit factor xa
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol
01/26/2005CN1571785A Synthesis of 4-[(z)-4-bromophenyl)(ethoxyimino) methyl]-1'-[(2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl-1, 4-'bipiperidine
01/26/2005CN1571784A Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same
01/26/2005CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
01/26/2005CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/26/2005CN1571781A 4-imidazolin-2-one compounds
01/26/2005CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1
01/26/2005CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/26/2005CN1571667A Inhibitors of dipeptidyl peptidase ó¶
01/26/2005CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines
01/26/2005CN1186326C Propane-1, 3-dione derivatives
01/26/2005CN1186322C Proline derivatives and use thereof as drugs
01/25/2005US6846930 Antiinflammatory agents; antiarthritic agents; rheumatic diseases; anticancer agents
01/25/2005US6846929 A hydroxyphenyl-2-benzotriazoles as light stabilizers having ultraviolet light absorbing activity; stabilizer with heat resistance, photostability, oxidation resistance
01/25/2005US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect
01/25/2005US6846834 Antiinflammation agents
01/25/2005US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/25/2005US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents
01/25/2005US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents
01/25/2005US6846825 Antibacterial agents
01/25/2005US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
01/25/2005US6846819 Bactericides compound containing acrylamide group
01/25/2005US6846818 Selective inhibitors of cyclooxygenase-2
01/25/2005US6846817 Nicotine receptor ligands
01/25/2005CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists
01/25/2005CA2170637C Pyridazinone derivatives or their salts, processes for their production, and anti-shock agents containing them
01/25/2005CA2103383C Quinazoline derivatives
01/20/2005WO2005005417A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators
01/20/2005WO2005005416A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators
01/20/2005WO2005005415A1 Indoles useful in the treatment of inflammation
01/20/2005WO2005005414A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
01/20/2005WO2005005413A1 Tacrine derivatives as inhibitors of acetylcholinesterase
01/20/2005WO2005005412A1 3-pyridylcarboxamide derivatives as pesticidal agents
01/20/2005WO2005005411A1 Substituted indole ligands for the orl-1 receptor
01/20/2005WO2005005410A1 A method for the preparation of enantiomerically pure mirtazapine
01/20/2005WO2005005409A1 Method for the production of substituted 2,6-dioxopiperidine-3-yl compounds
01/20/2005WO2005005397A1 5-substituted quinazolinone derivatives
01/20/2005WO2005005395A2 Arylamine-substituted quinazolinone compounds
01/20/2005WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists
01/20/2005WO2005005393A2 Cck-1 receptor modulators
01/20/2005WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
01/20/2005WO2005005386A1 Tetrahydrocarbazole derivatives and their pharmaceutical use
01/20/2005WO2005005380A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
01/20/2005WO2005005374A1 Aspartyl protease inhibitors
01/20/2005WO2005004866A1 Therapeutic agents useful for treating pain